Precision Optics Inc (POCI) Gross Profit Margin starting from the third quarter 2026 to third quarter 2025, Profitability Trends and Ranking, Fundamental Ratios - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Gross Margin
• EBITDA Margin
• Operating Margin
• Net Margin
• Pre-Tax Margin
• Effective Tax Rate
• Free Cash Flow Margin
• Cash Flow Margin
Precision Optics Corporation Inc   (NASDAQ: POCI)


Precision Optics Inc 's Gross Profit Margin by quarter

Trends, Rankings, Statistics


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

POCI Gross Profit Margin (Mar 31 2026)
Q3 		(Dec 31 2025)
Q2 		(Sep 30 2025)
Q1 		(Jun 30 2025)
Q4 		(Mar 31 2025)
Q3
Y / Y Revenue Change 108.04 %
Seq. Revenue Change 18.2 %
Revenue In Millions $8.71
Gross Profit Margin 23.61 %
Gross Profit Margin Total Ranking # 2744
Gross Profit In Millions $2.06
Y / Y Gross Profit Change 392.02 %
Seq. Gross Profit Change 904.85 %


Commenting Third Quarter 2026 Gross Profit Margin
Precision Optics Corporation Inc Gross Profit grew by 904.85 % in Q3 sequentially to 2 millions, while Revenue increased by 18.2 %, this led to improvement in the company's Gross Profit Margin to 23.61 %, Gross Profit Margin remained below Precision Optics Corporation Inc average.


Observing third quarter 2026 results within Medical Equipment & Supplies industry 159 other companies have achieved higher Gross Profit Margin. While Gross Profit Margin total ranking has impoved so far to 2744, from total ranking in the previous quarter at 3674.
Learn about Gross Margin
POCI's Gross Profit Margin third quarter 2026 Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 160
Healthcare Sector # 406
Overall # 2722

Gross Profit Margin Statistics
High Average Low
46.29 % 27.55 % 2.78 %
(Dec 31 2022)   (Dec 31 2025)


POCI Gross Income Trends • More of POCI's Profitabilty Ratios • POCI Stock Quotes and Charts


Other Gross Profit Margin Profitability Ratios
POCI's Cumulative Gross Profit Margin
Medical Equipment & Supplies Industry Gross Profit Margin Trends and Statistics
Healthcare Sector Gross Profit Margin Statistics
Gross Profit Margin Profitability Trends for overall market
POCI's Gross Profit Margin Profitability versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Gross Profit Margin
Lowest Ranking Gross Profit Margin
Gross Profit Margin Profit Margin for POCI's Competitors
Gross Profit Margin Profit Margin for Precision Optics Inc 's Suppliers
Gross Profit Margin Profit Margin for POCI's Customers

You may also want to know
POCI's Annual Growth Rates POCI's Profitability Ratios POCI's Asset Turnover Ratio POCI's Dividend Growth
POCI's Roe POCI's Valuation Ratios POCI's Financial Strength Ratios POCI's Gross Profit Growth
POCI's Roa POCI's Inventory Turnover Ratio POCI's Growth Rates POCI's Dividend Comparisons


Companies with similar Gross Profit Margin in the quarter ending Mar 31 2026, within Medical Equipment & Supplies Industry Gross Profit MarginMar 31 2026 MRQ Gross ProfitMar 31 2026 MRQ Revenue
Qhslab Inc   64.61 %$ 0.471  Millions$ 0.729  Millions
Clearpoint Neuro Inc   63.95 %$ 7.756  Millions$ 12.128  Millions
Utah Medical Products Inc  63.78 %$ 5.282  Millions$ 8.282  Millions
Biolife Solutions Inc   63.63 %$ 17.496  Millions$ 27.496  Millions
Stryker Corp  63.29 %$ 3,810.000  Millions$ 6,020.000  Millions
Dexcom Inc   62.98 %$ 750.300  Millions$ 1,191.300  Millions
Omada Health Inc   62.67 %$ 48.693  Millions$ 77.693  Millions
Femasys Inc   62.67 %$ 0.266  Millions$ 0.425  Millions
Resmed Inc   62.61 %$ 890.979  Millions$ 1,422.979  Millions
Masimo Corp  62.26 %$ 250.800  Millions$ 402.800  Millions
Enovis Corp  62.11 %$ 365.485  Millions$ 588.485  Millions
Dariohealth Corp   61.54 %$ 3.200  Millions$ 5.200  Millions
Koru Medical Systems Inc   61.47 %$ 7.231  Millions$ 11.765  Millions
Bausch and Lomb Corp  61.25 %$ 762.000  Millions$ 1,244.000  Millions
Vivos Therapeutics Inc   60.47 %$ 3.059  Millions$ 5.059  Millions
Nephros Inc   59.94 %$ 2.993  Millions$ 4.993  Millions
Beta Bionics Inc   59.91 %$ 16.437  Millions$ 27.437  Millions
Vaso Corporation  59.81 %$ 11.576  Millions$ 19.356  Millions
National Vision Holdings Inc   59.71 %$ 324.744  Millions$ 543.880  Millions
Infusystem Holdings Inc  58.43 %$ 19.682  Millions$ 33.684  Millions
Agape Atp Corporation  58.25 %$ 0.159  Millions$ 0.274  Millions
Transmedics Group Inc   58.16 %$ 101.161  Millions$ 173.933  Millions
Conmed Corporation  57.86 %$ 183.447  Millions$ 317.046  Millions
Embecta Corp   57.62 %$ 127.800  Millions$ 221.800  Millions
Haemonetics Corporation  57.09 %$ 198.212  Millions$ 347.212  Millions
Capsovision Inc   57.06 %$ 1.329  Millions$ 2.329  Millions
Teleflex Incorporated  56.16 %$ 307.426  Millions$ 547.426  Millions
Tandem Diabetes Care Inc   55.43 %$ 136.788  Millions$ 246.788  Millions
Integra Lifesciences Holdings Corp  55.36 %$ 216.982  Millions$ 391.918  Millions
Envista Holdings Corporation  55.33 %$ 390.100  Millions$ 705.100  Millions




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.